Spero Therapeutics's chart data is dated 2026-10-07. There is no active technical signal. There are 0 published signal records.
Spero Therapeutics last closed at $1.17 (-1.68%) on 2026-10-07. Listed on Nasdaq. Trailing 12 months PER is 9.2×. Its overall grade ranks 568 of 737 stocks in Healthcare.
About this company
Spero Therapeutics last closed at $1.17 (-1.68%) on 2026-10-07. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C · 568/737
Valuation grade B-
Related stocks
- Merck & Co.Customer
항생제 후보물질의 공동개발·상업화 파트너로 알려짐
- GSKCustomer
항생제 자산 관련 협력/라이선스 파트너로 연결
- PfizerCompetitor
감염증 치료제 분야의 대형 제약사 경쟁사
About Spero Therapeutics
- What technical signals does Spero Therapeutics (SPRO) have?
- Spero Therapeutics current technical signals: no active technical signal.
- Is Spero Therapeutics a cup-and-handle pattern?
- No. Spero Therapeutics has no valid Cup signal right now.
- What published figures are available for Spero Therapeutics?
- Market cap: $65.92M. Trailing 12 months PER: 9.2×. Latest quarter PBR: 1.53×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-08 dataset
Turn what you saw on this name into a strategy
Ask Q about Spero Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.